Zygmont Chester Stanley III

CIK 0001900657

Chief Financial Officer

Filings

Latest May 1, 2026

Issuers covered

Showing

6 of 6

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Zygmont Chester Stanley III. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Zygmont Chester Stanley III has filed

Ticker	Issuer	Filings	Last filed
REVB	Revelation Biosciences, Inc.	6	May 1, 2026

6 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
May 1, 2026	REVBRevelation Biosciences, Inc.	FTax	13,285	$1.10	$14,614
Feb 5, 2026	REVBRevelation Biosciences, Inc.	FTax	13,100	$1.65	$21,615
Jan 12, 2026	REVBRevelation Biosciences, Inc.	AGrant	78,145	$0.90	$70,331
Oct 31, 2025	REVBRevelation Biosciences, Inc.	AGrant	390,614	$1.28	$499,986
Feb 13, 2025	REVBRevelation Biosciences, Inc.	AGrant	15,048	$3.87	$58,236
Feb 28, 2023	REVBRevelation Biosciences, Inc.	Holdings only	-	-	-

Showing 1-6 of 6

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.